HCV: triplet salvage therapy yields impressive results

Access to the full content of this site is available only to registered healthcare professionals. Register to read more


  • Grazoprevir/uprifosbuvir/ruzasvir, with/without ribavirin (RBV), is highly effective for clearing HCV after failure of NS5A inhibitor-containing all-oral direct-acting antiviral (DAA) regimens.

Why this matters

  • Patients who fail DAAs have limited options.
  • Grazoprevir/uprif...